These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1867528)

  • 1. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis.
    Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S
    Artif Organs; 1991 Jun; 15(3):180-8. PubMed ID: 1867528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis.
    Ueki Y; Yamasaki S; Kanamoto Y; Kawazu T; Yano M; Matsumoto K; Miyake S; Tominaga Y; Iwamoto U; Suemitsu J; Matsuno Y; Sizume Y; Takenaka Y; Eguchi K
    Rheumatology (Oxford); 2000 Feb; 39(2):165-71. PubMed ID: 10725066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis.
    Ueki Y; Nakamura H; Kanamoto Y; Miyazaki M; Yano M; Matsumoto K; Miyake S; Tominaga T; Tominaga M; Yamasaki S; Eguchi K
    Ther Apher; 2001 Dec; 5(6):455-61. PubMed ID: 11800080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. 1991.
    Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S
    Ther Apher; 2000 Apr; 4(2):146-54. PubMed ID: 10805434
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis.
    Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Okada M; Ishizuka T; Kawakami M; Ohsuzu F
    Ther Apher; 1999 May; 3(2):178-85. PubMed ID: 10341394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell separating property and clinical effect of lymphocytapheresis with leukocyte removal filter.
    Akizawa T; Kinugasa E; Koshikawa S; Nishimura T; Kuroda H
    Prog Clin Biol Res; 1990; 337():23-5. PubMed ID: 2352982
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved on-line thoracic duct drainage for lymphocytapheresis.
    Sato T; Koga N; Nagano T; Ohteki H; Masuda T; Agishi T
    Int J Artif Organs; 1991 Dec; 14(12):800-4. PubMed ID: 1783455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytapheresis using a leukocyte removal filter.
    Shirokaze J
    Ther Apher; 2002 Aug; 6(4):261-6. PubMed ID: 12164794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytapheresis.
    Takenaka Y
    Artif Organs; 1996 Aug; 20(8):914-6. PubMed ID: 8853806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytapheresis in the treatment of rheumatoid arthritis: clinical and immunological studies.
    Indiveri F; Rogna S; Viglione D; Pierri I; Scudeletti M; Grifoni V
    Int J Artif Organs; 1985 May; 8(3):147-54. PubMed ID: 3875567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellsorba.
    Shibata H; Kuriyama T; Yamawaki N
    Ther Apher Dial; 2003 Feb; 7(1):44-7. PubMed ID: 12921114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate.
    Kempe K; Tsuda H; Yang K; Yamaji K; Kanai Y; Hashimoto H
    Ther Apher Dial; 2004 Jun; 8(3):197-205. PubMed ID: 15154871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and immunological effects of leukapheresis therapy using cotton-wool filter for patients with rheumatoid arthritis].
    Takeda M
    Ryumachi; 1996 Jun; 36(3):493-502. PubMed ID: 8779786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of filtration leukocytapheresis on rheumatoid arthritis with vasculitis.
    Hidaka T; Suzuki K
    Ther Apher; 1997 Aug; 1(3):212-4. PubMed ID: 10225740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effect of lymphocytapheresis on patients with HTLV-I-associated myelopathy (HAM)].
    Kubota R; Nakagawa M; Nakamura A; Osame M
    Rinsho Shinkeigaku; 1992 Sep; 32(9):984-8. PubMed ID: 1300272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytapheresis--a feasible treatment for rheumatoid arthritis.
    Emery P; Smith GN; Panayi GS
    Br J Rheumatol; 1986 Feb; 25(1):40-3. PubMed ID: 3942846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
    Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Kataharada K; Ishizuka T; Kawakami M; Nakamura H
    Arthritis Rheum; 1999 Mar; 42(3):431-7. PubMed ID: 10088764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis.
    Eguchi K; Saito K; Kondo M; Hidaka T; Ueki Y; Tanaka Y;
    Mod Rheumatol; 2007; 17(6):481-5. PubMed ID: 18084700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease.
    Kawamura A; Saitoh M; Yonekawa M; Horie T; Ohizumi H; Tamaki T; Kukita K; Meguro J
    Ther Apher; 1999 Nov; 3(4):334-7. PubMed ID: 10608731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytapheresis in combination with immunosuppressive drugs for refractory myasthenia gravis: two-color flow cytometric analysis of changes in peripheral blood lymphocyte subsets.
    Furutama D; Nakajima H; Shinoda K; Makino S; Ohsawa N
    Eur Neurol; 1995; 35(5):270-5. PubMed ID: 8542915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.